Keck School of Medicine
Economic Model Says Cervical Cancer Co-Testing with mRNA-Based MDx Could Save Lives and Money
Premium
The Hologic-funded model predicted co-testing would lead to a lifetime savings of $39 per woman, with high cancer detection sensitivity and fewer false positive results.
Keck Graduate Institute-led Team Begins New NIH Grant to Develop Point-of-Care Tuberculosis MDx
Premium
NEW YORK (GenomeWeb) — A public-private team led by researchers at the Keck Graduate Institute of Life Sciences has been awarded just over $600,000 by the National Institutes of Health for the first year of a four-year project to further develop its point-of-care nucleic acid testing platform for
Cancer Genetics, Keck Researcher Team on Lymphoma Markers
NEW YORK (GenomeWeb) – Cancer Genetics today said that it will collaborate with a researcher at Keck Medicine of the University of Southern California to identify genomic markers of diffuse large B-cell lymphoma.
WaferGen Biosystems and collaborators in the laboratory of Jo Vandesompele at the University of Ghent have developed a PCR-based target enrichment workflow using WaferGen's SmartChip real-time PCR system, the company said this week.
The grant will help USC spinout Pivotal Biosciences, which was co-founded by researcher Alan Epstein, push the immunotherapy through to clinical trials — a task that would otherwise be near impossible for the company due to a dearth of private funding caused by the recent financial meltdown.
Jun 26, 2009